University of Wisconsin-Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination -- including a COVID-19 vaccine from Moderna Therapeutics that has advanced to clinical trials with humans.
There's considerable controversy over whether "COVID toes"--red sores or lesions on the feet and hands in children and young adults--are truly caused by COVID-19. A new study published in the British Journal of Dermatology provides evidence in support of the link.
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published in the Journal of Hepatology. The risk of liver cirrhosis increases if the levels of this biomarker rise between two testing occasions.
Studies describing various methods of decontamination to allow safe reuse of N95 respirators are summarized in this article.
Researchers from the Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center (BMC) have assembled the largest repository of patient derived stem cells (iPSCs) from patients with alpha-1 antitrypsin deficiency (AATD).
A collaborative team of Salk Institute and UC San Diego scientists have created a novel microbiome-based diagnostic tool that, with the accuracy of the best physicians, quickly and inexpensively identifies liver fibrosis and cirrhosis over 90 percent of the time in human patients. The non-invasive method relies on an algorithm to analyze patient stool samples--which contains traces of what lives in the gut--and could lead to improved patient care and treatment outcomes for liver disease.
Research from the University of Bath in the UK suggests the best medicine-related support comes from hospital pharmacists, yet few discharged patients use helplines set up for this purpose.
More research must be done to investigate the role of air pollution on the epigenome in patients with interstitial lung diseases (ILDs), in order to develop strategies that minimize the effects of these pollutants, according to a new article published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Weekly changes in U.S. deaths from March 1 through May 30, 2020, due to any cause and deaths due to pneumonia, influenza or COVID-19 are investigated in this observational study.
Allogeneic stem cell transplantation can cause a loss of protective goblet cells from the colon's inner lining, which can be fatal. But boosting those cells beforehand could improve the outcome.